Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Di Guglielmo Disease

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Di Guglielmo Disease in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Supino, R1
Gibelli, N1
Galatulas, I1
Zunino, F1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Di Guglielmo Disease

ArticleYear
Influence of calcium and calcium-modulating agents on differentiation of murine erythroleukaemia cells.
    Cell biology international reports, 1985, Volume: 9, Issue:12

    Topics: 4-Aminopyridine; Aminopyridines; Amrinone; Animals; Calcimycin; Calcium; Calcium Channel Blockers; C

1985